Plan. A bit about TB What I do What I should do

Similar documents
Riga Dr Al Story

People not Pathogens. Al Story

TB control. Assumptions. Reality. Symptomatic patients seek care. Patients and professionals don t recognise symptoms

Social determinants of infectious diseases

Activities in 2010, Priorities for 2011

Mobile TB screening among drug users and homeless persons in Rotterdam: after the outbreak

Clive Richardson Panteion University of Social & Political Sciences, Athens & Greek Reitox Focal Point

TB the basics. (Dr) Margaret (DHA) and John (INZ)

Prevention and control of hepatitis B and C in the European Region of WHO

DHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General , Hepatitis C Prevention and Control within Maryland

HIV and Tuberculosis in Eastern Europe

The Western Pacific Region faces significant

Global epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos

Third Annual World TB Day Symposium: Showcasing Clinical and Epidemiologic Studies on TB at the UW. March 24, 2016

Communicable Disease. Introduction

Outcomes and methods of analysis. Primary outcomes: The number of eligible clients at a hostel venue screened for active pulmonary tuberculosis by MXU

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

The WHO END-TB Strategy

Management of MDR TB. Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore

Tuberculosis surveillance in Germany. Data of the tuberculosis report 2013

Fact sheets on sustainable development goals: health targets. Viral Hepatitis

Diagnosis & Management of Latent TB Infection

Item 4. Sexual Health and Blood Borne Virus Strategy Strategy for Sexual Health and Blood Borne Viruses. Background

TB EPIDEMIOLOGY: IMPACT ON CHILDREN. Anneke C. Hesseling Desmond Tutu TB Centre Department Paediatrics and Child Health Stellenbosch University

Global, National, Regional

HIV AIDS and Other Infectious Diseases

HIV, HBV and HCV testing policy experiences and lessons learned.

Syringe Exchange Programs December 2005

Contextual overview with reference to MDG Goal 6 and projection for Post-2015

Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework

TB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research

CHAPTER 2. Literature review

Fundamentals of Tuberculosis (TB)

2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

CMH Working Paper Series

Government of Canada Federal AIDS Initiative Milestones

12/10/2018. Agenda. Screening for Latent TB among Migrants in Italy. Agenda. Conflict of interest. LTBI definition from a pragmatic point of view

TB/HIV in the WHO European Region Overview, Priorities & Response

T uberculosis control aims to reduce mortality and morbidity

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Epidemiological trends of TB in Eastern Europe TB and migration

Let s Talk TB. A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Primer on Tuberculosis (TB) in the United States

Management of Pediatric Tuberculosis in New Jersey

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

Fact sheets on sustainable development goals: health targets. Tuberculosis

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

Programmatic latent tuberculosis control in the European Union and candidate countries - Draft conclusions

Elizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist, NH GEISELMED.DARTMOUTH.EDU GEISELMED.DARTMOUTH.

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

Multidrug-resistant Tuberculosis - World, Europe, Switzerland

TB Control in Finland - the role of THL

Running head: TUBERCULOSIS 1

Diagnosis of HIV and TB in the Finnish primary health care. Pekka Suomalainen M.D

Tuberculosis Procedure ICPr016. Table of Contents

Children as Sentinels for Transmission and Policy Response Mercedes Becerra, ScD

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition

Tuberculosis Epidemiology and Prospects for Control

Hepatitis C Strategy. About us. What is hepatitis C?

Tuberculosis. Anne Dunleavy. Excellence in specialist and community healthcare

Tuberculosis (TB) Fundamentals for School Nurses

Tuberculosis in Alameda County, 2012

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT

Global, National, Regional

Study of Multi-Drug Resistance Associated with Anti-Tuberculosis Treatment by DOT Implementation Strategy in Pakistan

TB: A Supplement to GP CLINICS

Drug Interactions Lisa Armitige, MD, PhD November 17, 2010

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

The Clinical Characteristics and Predictors of Treatment Success of Pulmonary Tuberculosis in Homeless Persons at a Public Hospital in Busan

Characteristics of Mycobacterium

Contact Follow-Up and Treatment of LTBI in Households of Infectious Cases in Pakistan

3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019

Health and well-being a perspective from WHO

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Globally, it is well documented that certain

Yakima Health District BULLETIN

Economics of Vaccine Development A Vaccine Manufacturer s Perspective

EXAMINING THE EPIDEMIOLOGY OF TUBERCULOSIS IN MIGRANTS TO THE UK TO INFORM EVIDENCE- BASED SCREENING POLICIES.

TUBERCULOSIS. Famous victims in their intellectual prime: Chopin, Paganini, Thoreau, Keats, Elizabeth Browning, Brontës

Shabir A. Madhi. Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality.

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics

Why do we need SD goals on climate change, environment and health

Why can t we eliminate tuberculosis?

Contact Investigation San Antonio, Texas January 14-15, 2013

Mycobacterium tuberculosis. Lecture (14) Dr.Baha, AL-Amiedi Ph. D.Microbiology

Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection

Excess Winter Deaths. June 2017

Formative Research results

Supplementary Appendix

Transcription:

B R E A K F A S T

Plan A bit about TB What I do What I should do

575,475 583,350 810,120 667,228 755,605 7,753,555 1,068,532 2,199,500 3,442,675 1,698,957 3,255,944 2,724,347 745,514

121 39 58 113 3,440 320 515 143 269 256 580 487 91

Western European Capital Cities (2009 pop. > 0.5M) Oslo Helsinki Copenhagen Athens Amsterdam Stockholm Brussels Vienna Paris Rome Madrid Berlin London 121 58 113 91 143 39 320 256 515 487 580 269 3,440 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000

Western European Capital Cities (2009 pop. > 0.5M) Oslo 121 Helsinki 58 Copenhagen 113 Athens 91 Amsterdam 143 Stockholm Brussels 39 320 2,992 Vienna 256 Paris 515 Rome 487 Madrid 580 Berlin 269 London 3,440 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000

709,145 558,165 7,753,555 1,711,466 1,711,466 1,233,211 1,249,798 1,944,226

305 178 3,440 128 304 321 457 1,694

Eastern European Capital Cities (2009 pop. > 0.5M) Vilnius Riga Prague Sofia Budapest Warsaw 178 305 128 457 321 304 Bucharest 1,694 London 3,440 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000

Eastern European Capital Cities (2009 pop. > 0.5M) Vilnius Riga Prague Sofia Budapest Warsaw 178 305 128 457 321 304 3,387 Bucharest 1,694 London 3,440 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000

TB: Comparison case numbers UK, US and London Source: Centers for Disease Control and Health Protection Agency 2013

Infection and Inequality Infectious diseases disproportionately affect vulnerable groups in every single EU Member State [1] TB especially correlates with income equality [2] Vulnerability to infectious diseases is further exacerbated by economic recession [3] 1. Semenza JC, Giesecke J (2008) Intervening on infections in inequality. American Journal of Public Health 98: 787 792. 2. Suk JMD, Buscher G, Semenza JC (2009) Wealth inequality and TB elimination in Europe. Emerging infectious diseases 15: 1812 1814. 3. Suhrcke M, Stuckler D, Suk JE, et al. The impact of economic crises on communicable disease transmission and control: a systematic review of the evidence. PLoS One. 2011;6(6):e20724. Epub 2011 Jun 10.

Janssens JP, Rieder HL. Eur Respir J 2008;32:1415-6

TB in London Highest rates of TB in Western Europe [1] 10.2% of cases are now drug resistant [2] Significant increase in MDRTB [2] Homelessness independently associated with MDRTB [1] European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2012. Stockholm: European Centre for Disease Prevention and Control, 2012. http://ecdc.europa.eu/en/publications/publications/1203-annual-tb-report.pdf [2] Any first line Drug (INH, Rif, E,Z) Tuberculosis in London: Annual report (2011 data). Health Protection Agency London Regional Epidemiology Unit, September 2012.

DR 2011

Percentage of Households below 60% of median income http://data.london.gov.uk

Inequality

UK born (20%) Foreign born (80%)

Britain will be 'swamped' by TB Rise of drug-resistant tuberculosis in the UK 'is linked to immigration Health Minister: Immigrants to blame for record rise in TB Time Bomb - Migrants to bring drug-resistant TB superbug to UK

London TB Profile study - TB Prevalence 1200 1000 800 600 400 200 0 Story A et al. Thorax. 2007 Aug;62(8):667-71

17% of all cases 30% of all infectious cases 50% of all infectious drug resistant cases Story A et al. Thorax. 2007 Aug;62(8):667-71

Hard-to-reach (1:6)

Active case finding Core business Circa 10K screens per year - 290 sessions Support the most complex cases >1,500 referrals so far (34% DR - 68 MDR, 6 XDR) Locate & return to service >250 active TB cases returned so far Training / awareness Peer educators 3 rd Sector non-clinical professionals

Detection (1960 s)

Detection (21 st C) Dutch fleet

XX/07/2005

XX/12/2006

XX/07/2008

CXR 1 in 4 referred start TB treatment Two-thirds less likely to be infectious Story A, Aldridge RW, Abubakar I, Stagg HR, Lipman M, Watson JM, Hayward AC. Active case finding for pulmonary tuberculosis using mobile digital chest radiography: an observational study. Int J Tuberc Lung Dis. 2012 Nov;16(11):1461-7

Housing - TB hostel

Impact Early detection prevents future cases Overall 84% of active cases detected or referred are treatment engaged or completed

Highly cost effective

Next steps TB HCV HBV HIV Flu PPV HBV

N I I S Mobile Health Units NIIS Infectious diseases TB 1) Active pulmonary TB [CXR and PCR] 2) TB infection [abnormal CXR >35] * Blood Borne Viruses [Hepatitis B & C, HIV] [Saliva swabs] Venous blood for saliva positives * Vaccine preventable diseases Hepatitis B 1) if neg. on saliva 2) no/incomplete history 3) >5 years Influenza all seasonally PPV - pneumococcal pneumoniae and invasive disease [all not vaccinated] Health MOT Rapid Health Survey [standardised] Health MOT from local primary care specialists [agreed and determined locally] Peer led health promotion * Those requiring full venous bloods will also have IGRA

Force of infection Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996 May;86(5):655-61

Why are we here

Phthisie des pauvres - Guerre au bacille The states responsibility to improve the lot of the masses The physicians responsibility to kill the bacilli

Pidoux What a calamity such a result would be! poor consumptives sequestered like lepers; the tenderness of their families at war with fear and selfishness. Hermann Pidoux, in Discussion sur la tuberculose (at Academy of Medicine, December 3 and 10, 1867), Bulletin de l Académie impériale de médecine 32 (1866 67): 1254 1255, 1261.

Pidoux A medicine of the species above and beyond the medicine of the individual Tuberculosis requires more advanced and more social solutions Hermann Pidoux, in Discussion sur la tuberculose (at Academy of Medicine, December 3 and 10, 1867), Bulletin de l Académie impériale de médecine 32 (1866 67): 1254 1255, 1261.

Pidoux 1: Diatheses Constitutional predisposition Hermann Pidoux, in Discussion sur la tuberculose (at Academy of Medicine, December 3 and 10, 1867), Bulletin de l Académie impériale de médecine 32 (1866 67): 1254 1255, 1261.

Pidoux 2: External Poverty (misère) ignorance overwork malnutrition unsanitary housing Hermann Pidoux, in Discussion sur la tuberculose (at Academy of Medicine, December 3 and 10, 1867), Bulletin de l Académie impériale de médecine 32 (1866 67): 1254 1255, 1261.

Pidoux 3: Internal Poverty (misère) various chronic diseases laziness habits of luxury flabbiness - excesses at table the torments of ambition Hermann Pidoux, in Discussion sur la tuberculose (at Academy of Medicine, December 3 and 10, 1867), Bulletin de l Académie impériale de médecine 32 (1866 67): 1254 1255, 1261.

Pidoux Central to Pidoux s proposed solution was an unprecedented government-sponsored network of local associations to investigate and remedy the social causes of tuberculosis at the local level Hermann Pidoux, in Discussion sur la tuberculose (at Academy of Medicine, December 3 and 10, 1867), Bulletin de l Académie impériale de médecine 32 (1866 67): 1254 1255, 1261.

Robert Koch - March 24th 1882

An Address on the MODERN TREATMENT OF PULMONARY PHTHISIS By C. Theodore Williams M.D. F.R.C.P. London CONSULTING PHYSICIAN TO THE HOSPITAL FOR CONSUMPTION AND DISEASES OF THE CHEST, BROMPTON Koch s brilliant discovery, while it has largely assisted diagnosis it cannot be said to have contributed much to the progress of treatment. It was the signal for an enthusiastic outburst of antiseptic or bacillicide measures. All efforts short of destroying the patient were directed to slaughter the Tubercle bacillus. The Lancet. Nov 3, 1894 pp 1021-

A Lecture on the NEW METHOD OF TREATMENT OF CONSUMPTION AND OTHER DISEASES OF THE RESPIRATORY ORGANS BY GASEOUS RECTAL INJECTIONS By I. Burney Yeo M.D. F.R.C.P. PROFESSOR OF CLINICAL THERAPEUTICS IN KING S COLLEGE, AND PHYSICIAN TO KING S COLLEGES HOSPITAL The Lancet. April 16, 1887 pp 761-65

Notification rate per 100,000 population Death rate per 100,000 population 350 300 250 200 150 1963 Rifampicin 1962 Ethambutol 1954 Pyrazinamide 1952 Isoniazid 1949 p-aminosalicylic acid 1943 Streptomycin 160.0 140.0 120.0 100.0 80.0 60.0 100 40.0 50 20.0 0 0.0 1913 1916 1919 1922 1925 1928 1931 1934 1937 1940 1943 1946 1949 1952 1955 1958 1961 1964 1967 1970 1973 1976 1979 1982 1985 1988 1991 1994 1997 2000 Year

A new approach to controlling a social disease Political commitment Emphasis on prevention & control measures Financial support Health education of the general public Tuberculosis as a Disease of the Masses and How to Combat it. Knopf, 1901.

Without Koch s discovery, the socio-economic character of tuberculosis would have been clearer, and a demand for redistribution of the wealth of the community would have been a much more important issue Waaler 1982

Thanks to you and the outreach team, and our partners, punters and pundits